Skip to main content
Clinical Trials/NCT02551757
NCT02551757
Completed
Phase 1

Randomized Trial of Continuous Positive Airway Pressure in Patients Undergoing Intensive Inpatient Rehabilitation After Acute Stroke

University of Washington1 site in 1 country40 target enrollmentJune 2013

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Stroke
Sponsor
University of Washington
Enrollment
40
Locations
1
Primary Endpoint
Feasibility of Enrolling Eligible Stroke Patients Admitted to Inpatient Rehabilitation for an Acute Ischemic or Hemorrhagic Stroke Into a Pilot, Randomized Clinical Trial of Active Versus Sham CPAP.
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to assess the effect of continuous positive airway pressure (CPAP) on functional outcome in patients with acute stroke, the investigators conducted a sham-controlled, double-blind pilot trial during inpatient rehabilitation.

Patients with acute stroke were recruited and randomly assigned to auto-titrating or sham-CPAP during their rehabilitation stay.

Detailed Description

All acute stroke patients admitted to the inpatient rehabilitation service at the University of Washington were invited to participate in the study. Given the high prevalence of obstructive sleep apnea (OSA) in this population, no screen for OSA was performed. Enrolled patients were assigned randomly to active-CPAP with auto-titrating pressures or to sham-CPAP with an otherwise identical device but with pressures ≤ 1 cm water. Subjects used active or sham-CPAP for the duration of inpatient rehabilitation, but no longer than 28 days. CPAP compliance was assessed by memory card that recorded mask-on time. Other information on download, such as apnea-hypopnea index, was only available on active-CPAP and not assessed by investigators in real time. In this study, the investigators defined tolerance as any continued use of CPAP at night and adherence as mean hours of CPAP use per night in those who were CPAP tolerant.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
July 2015
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sandeep Khot

Associate Professor, Dept. of Neurology

University of Washington

Eligibility Criteria

Inclusion Criteria

  • greater than 18 years of age
  • admitted to an inpatient rehabilitation unit at the University of Washington
  • head CT or brain MRI demonstrating an ischemic or hemorrhagic stroke
  • enrolled in another research study

Exclusion Criteria

  • stroke was a subarachnoid hemorrhage or due to a secondary cause (vascular malformation, vasculitis, brain tumor, head trauma, or predisposition to bleeding)
  • history of CPAP use, advanced chronic lung disease requiring supplemental oxygen, heart failure (NYHA class III or IV)
  • require a nasogastric feeding tube.

Outcomes

Primary Outcomes

Feasibility of Enrolling Eligible Stroke Patients Admitted to Inpatient Rehabilitation for an Acute Ischemic or Hemorrhagic Stroke Into a Pilot, Randomized Clinical Trial of Active Versus Sham CPAP.

Time Frame: 18 months

Number of stroke patients willing to participate during inpatient rehabilitation over 18 months and be randomized in this clinical trial to treatment with active or sham auto-titrating CPAP.

Secondary Outcomes

  • Hours of CPAP Per Night(up to 28 days)
  • Median Change in the Functional Independence Measure (FIM) Between Admission and Discharge From the Rehabilitation Unit Comparing Active-CPAP Versus Sham-CPAP.(Baseline and discharge up to 28 days)

Study Sites (1)

Loading locations...

Similar Trials